Scoop has an Ethical Paywall
New appointment for technology development growth
July 29, 2005
New appointment for technology development growth
AUCKLAND, July 29, 2005: Joining a team taking
growth in commercialising the intellectual property of The
University of Auckland to a new level was a key attraction
in taking up the appointment of General Manager Technology
Development at Auckland UniServices Limited, says Will
Charles who starts
in his new role at the University's
commercialisation company on August 1.
Most recently with Novartis Korea as Business Unit Head, Primary Care and previously with Novartis New Zealand, Mr Charles has worked at senior commercial level with a wide variety of life science businesses in Europe, Asia and New Zealand over the past 18 years.
"I see joining UniServices at this time as a terrific opportunity, "he said. "The University of Auckland has shown it has several areas where it can rank among the world's very best and I'm looking forward to helping drive further growth in commercialising the opportunities this capability creates, "he said.
Welcoming Mr Charles's appointment, Dr Peter Lee, UniServices' CEO, said technology development, where UniServices commercialises new intellectual property in addition to managing ongoing contract research, is a key focus for the company. "Will brings important commercial skills and experience at a time when we are targeting strong growth in this area, "he said.
"Increasingly, global investors will go wherever they see the best research and we are committed to take advantage of this in developing new opportunities." In recent years UniServices has become Australasia's largest organisation commercialising university research and been involved in forming several significant company start ups in the health sector and in multi-million licensing deals in cancer research, engineering, medical software, educational products and new power transmission technologies.
Mr Charles has a Bachelor of Science with Honours from St Andrews University, Scotland, a Diploma in Business (Finance) from The University of Auckland and has attended executive courses at Harvard Business School and Insead. Raised in Kenya, he has held executive positions with GlaxoSmithKline, Roche and Celltech. He made New Zealand his adoptive home in 1993 and returns to Auckland with his family.
ENDS
Business Canterbury: Urges Council To Cut Costs, Not Ambition For City
Wellington Airport: On Track For Net Zero Emissions By 2028
Landcare Research: ANZAC Gall Fly Release Promises Natural Solution To Weed Threat
NZ Anti-Vivisection Society: Auckland Rat Lovers Unite!
University of Canterbury: $1.35 Million Grant To Study Lion-like Jumping Spiders
Federated Farmers: Government Ends War On Farming
